EzriCare Artificial Tears Lawsuit Indicates Exposure to Bacteria in Eye Drops Caused Vision Damage
Lawsuit indicates EzriCare eye drop infection occurred months after an Artificial Tears recall over Pseudomonas aeruginosa contamination.
Lawsuit indicates EzriCare eye drop infection occurred months after an Artificial Tears recall over Pseudomonas aeruginosa contamination.
The FDA has given manufacturers of eye drops containing amniotic fluid 30 days to respond to a letter indicating they are selling unapproved medical products.
Investigators found that contaminated eye drops caused several nursing home eye infection outbreaks last year, months before a nationwide Artificial Tears recall was announced
When tested, the recalled Artificial Tears used by the firefighter were found to contain large amounts of Pseudomonas Aeruginosa bacterial contamination.
Recalled Artificial Eye Ointment carries the same risk of bacterial contamination that resulted in recent Artificial Tears eye drops recall, FDA warns.
Lawsuit alleges contaminated eye drops caused vision loss and surgery, joining a growing number of Artificial Tears lawsuits filed since a recall was announced due to bacterial contamination.
Lawsuit alleges contaminated eye drops caused a Pseudomonas aeruginosa infection and antibiotics did little to help fight off the treatment-resistant bacterial contamination
Florida woman had to undergo eye surgery after normal treatments failed to work agains a Pseudomonas Aeruginosa eye drops infection
Dozens of infections have been linked to the contaminated eye drops, including at least one death, and a growing number of Artificial Tears lawsuits and class action claims are being pursued
Class action lawsuit over recalled eye drops alleges Delsam Pharma and EzriCare Artificial Tears were not adequately treated to prevent bacterial contamination.